Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2003
10/15/2003CN1448180A Prep. of capsule for promoting hepatocyte growth hormone
10/15/2003CN1448179A Application of bicoptis for injection in preparation of medicine for curing serious acute respiratory tract syndrome
10/15/2003CN1448174A Application of cymose buckwheat rhizome in preparation of antiviral drug
10/15/2003CN1448167A Medicine for treatment of pelvic inflammation, its preparation and preparing method
10/15/2003CN1448163A Hepatosis treating traditional Chinese medicine formula
10/15/2003CN1448154A Medicine for treating exopathic disease and preparation process thereof
10/15/2003CN1448153A Ointment for treating dermatopathy and preparing process thereof
10/15/2003CN1448148A New method prepared Chinese herbal medicine capable of preventing and curing AIDS and preparation method thereof
10/15/2003CN1448136A Furbenicillin antiseptic composite medicine
10/15/2003CN1448135A High potency antiseptic composite medicine
10/15/2003CN1448129A Garlicin and garlic oil cyclodextrin derivatives inclusion compound and method for making same
10/15/2003CN1124276C Rapamycin derivatives
10/15/2003CN1124159C Vaccines against aujeszky's disease and other animal diseases containing pseudorabies virus mutants
10/15/2003CN1124157C Pharmaceutical compositions
10/15/2003CN1124151C Medicine for treating tuberculosis
10/15/2003CN1124148C Traditional Chinese medicine for curing viral myocarditis and its preparing process
10/15/2003CN1124142C Chinese medicine for treating cold and its preparing process
10/14/2003US6632962 Caspase inhibitors and uses thereof
10/14/2003US6632946 Tetracyclic analogues of camptothecins, their preparation processes, their use as medicaments and the pharmaceutical compositions containing them
10/14/2003US6632945 Treating inflammation, autoimmune diseases, destructive bone disorders, proliferative disorders, infections, neurvous system disorders, reperfusion/ischemia in stroke, cardiovascular disorders, hypoxia, edema, fever, pain
10/14/2003US6632836 To treat autoimmune disorders, cardiac arrhythmias and the like
10/14/2003US6632831 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
10/14/2003US6632826 Carbocyclic HIV protease inhibitors
10/14/2003US6632825 Picornaviral 3C protease enzyme inhibitors; amide ester or amide acid derivatives
10/14/2003US6632816 Aromatic derivatives as HIV aspartyl protease inhibitors
10/14/2003US6632809 Gyrase inhibitors and uses thereof
10/14/2003US6632803 Pharmaceutical formulations containing voriconazole
10/14/2003US6632793 Immunological activity for a peptide of the limulus anti-LPS factor
10/14/2003US6632664 Foreign gene inserted into an untranslated region in the genome
10/14/2003US6632647 Use of strains of parapoxvirus ovis against organ fibrosis
10/14/2003US6632640 Virus replicon vector which contains nucleic acid encoding exotoxin; nucleotide sequence expresses a peptide product that does not bind to major histocomptability complex on T-cells
10/14/2003US6632454 Multilayer pharmaceutical product for release in the colon
10/14/2003US6632443 Water-soluble compositions of bioactive lipophilic compounds
10/14/2003US6632441 Mutants of streptococcal toxin a and methods of use
10/14/2003US6632437 Immunogenic polysaccharide-protein conjugates containing poly α(2→8), α(2→9) NeuNAc capsular polysaccharides
10/14/2003US6632434 Leptospiral major outer membrane protein, LipL 32
10/14/2003US6632432 Plasma from donors immunized with Staphylococcal epidermidis vaccine comprising antigens in TCA (trichloroacetic acid) extractions
10/14/2003US6632430 Administering enzyme inhibitors of S-adenosyl methionine synthetase (SAMS), of S-adenosyl homocysteine hydrolase (SAHH) and of transmethylases, RNA transmethylase and DNA transmethylase; antidotes; detoxification
10/14/2003CA2385777A1 Use of anti-tnf.alpha.antibodies and another drug
10/14/2003CA2291994C Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents
10/14/2003CA2223505C Anti-fungal and anti-bacterial histatin-based peptides
10/09/2003WO2003083442A2 Life sciences business systems and methods
10/09/2003WO2003083083A2 Methods of using flt3-ligand in immunization protocols
10/09/2003WO2003083058A2 Replikin peptides in rapid replication of glioma cells and in influenza epidemics
10/09/2003WO2003083039A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/09/2003WO2003082926A2 Antimicrobial polymer conjugates
10/09/2003WO2003082919A2 Ox40r binding agents
10/09/2003WO2003082908A2 Use of the p17 protein of hiv in isolated form for the preparation of a medicament for administration to hiv seropositive patients, as well as pharmaceutical compositions comprising said protein
10/09/2003WO2003082881A2 Pyridoxal-5-phosphate derivatives as hiv integrase inhibitors
10/09/2003WO2003082872A1 Novel pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy
10/09/2003WO2003082869A1 Azaindoles as inhibitors of c-jun n-terminal kinases
10/09/2003WO2003082868A1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
10/09/2003WO2003082864A2 Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them
10/09/2003WO2003082862A1 Anti-inflammatory morpholin-acetamide derivatives
10/09/2003WO2003082853A1 New compounds
10/09/2003WO2003082848A1 Pyranon and pyrandion inhibitors of hepatitis c virus rna-dependent rna polymerase
10/09/2003WO2003082841A1 5-substituted 1,1-dioxo-`1,2,5!thiazolidine-3-one derivatives as ptpase 1b inhibitors
10/09/2003WO2003082829A1 New aryl imidazoles and related compounds as c5a receptor modulators
10/09/2003WO2003082827A1 Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents
10/09/2003WO2003082813A2 Improvements in pharmaceutical compositions
10/09/2003WO2003082808A1 Benzamide derivatives
10/09/2003WO2003082787A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003WO2003082392A2 Oxygenating agents for enhancing host responses to microbial infections
10/09/2003WO2003082350A2 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
10/09/2003WO2003082306A1 Lactobacillus iners for the enhancement of urogenital health
10/09/2003WO2003082277A1 Thiazol-2-yl-imine compounds as pde-7 inhibitors
10/09/2003WO2003082273A1 Solubilization of weak bases
10/09/2003WO2003082266A1 Use of topoisomerase inhibitors and heat shock protein 90 inhibitors for use in chemotherapy
10/09/2003WO2003082260A2 Tuberculosis treatment using pleuromutilin derivatives
10/09/2003WO2003082259A1 Natural phenolic products and derivatives thereof for protection against neurodegenerative diseases
10/09/2003WO2003082243A1 Oral suspension formulation
10/09/2003WO2003082216A2 Neuroprotectant methods, compositions, and screening methods thereof
10/09/2003WO2003082209A2 Cochleates made with purified soy phosphatidylserine
10/09/2003WO2003082196A2 Combination therapy using trefoil peptides
10/09/2003WO2003082193A2 Suramin and derivatives thereof as topical microbicide and contraceptive
10/09/2003WO2003082184A2 Truncated lysostaphin molecule with enhanced staphylolytic activity
10/09/2003WO2003082011A1 Use of non-antibacterial tetracycline analogs and formulations thereof for the treatment of bacterial exotoxins
10/09/2003WO2003045328A3 Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof
10/09/2003WO2003037367A3 New bacterium causing poultry disease and vaccine derived thereof
10/09/2003WO2003034981A3 Prevention of recurrent viral disease
10/09/2003WO2003028661A3 Adjuvanted meningococcus compositions
10/09/2003WO2003028626A3 Glucagon-like peptides (glp-1) and treatment of respiratory distress
10/09/2003WO2003022880A3 Synthetic hcv envelope proteins and their use for vaccination
10/09/2003WO2003000878A3 Use of fkbp chaperones as expression tool
10/09/2003WO2002102828A3 Chimeric flavivirus vectors
10/09/2003WO2002097075A3 Capping enzyme of flavivirus and utilization of this protein in a process to test drugs with antiviral properties
10/09/2003WO2002092004A3 Use of hmg fragment as anti-inflammatory agents
10/09/2003WO2002083627A3 Ligands des integrins avss6
10/09/2003WO2002080939A3 Ionene polymers and their use as antimicrobial agents
10/09/2003WO2002078682A3 Estrogen replacement therapy
10/09/2003WO2002076286A3 Prognostic methods for breast cancer
10/09/2003WO2002059154A3 Neutralizing human monoclonal antibodies against hiv-1, their production and uses
10/09/2003WO2002056905A3 Molecular antigen array
10/09/2003WO2002055063A3 Fumaric acid amides
10/09/2003WO2002034284A3 Methods of therapy for hiv infection
10/09/2003WO2002033099A3 Human kinases
10/09/2003WO2002021926A3 An antimicrobial composition
10/09/2003WO2002016612A3 Genes and proteins, and their uses
10/09/2003WO2002012290A3 Sid polypeptides binding to pathogenic strain of the hepatitis c virus
10/09/2003WO2002009686A3 Cdc25 phosphatase inhibitors
1 ... 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 ... 1798